Literature DB >> 14978727

Treatment with the antiepileptic drugs phenytoin and gabapentin ameliorates seizure and paralysis of Drosophila bang-sensitive mutants.

Elaine R Reynolds1, Eric A Stauffer, Laura Feeney, Elizabeth Rojahn, Benjamin Jacobs, Carol McKeever.   

Abstract

Drosophila bang-sensitive (bs) mutants exhibit a stereotypic seizure and paralysis following exposure to mechanical shock. In a physiological preparation, seizures and failures corresponding to the defective behavior are observed in response to high frequency stimulation. The amplitude of the stimulus necessary to produce bs behavior, or seizure threshold, varies with bs mutant and its gene dosage. In many respects, the bs defects are similar to those observed in mammalian seizure disorders. Antiepileptic drugs (AEDs) were administered by feeding to easily shocked(2) (eas(2)), a representative bs mutant. The mean recovery times of treated flies were examined in comparison to control cultures. Some of the drugs administered, including carbamazeprine, ethosuximide, and vigabactrin, had little or no effect on the bs behavior of eas(2). Gabapentin, however, showed a reduction in mean recovery time with chronic drug exposure. Phenytoin also had a significant effect on the bs behavior of treated flies. There was a reduction of both mean recovery time and the percentage of flies that displayed bang-sensitive behavior with both acute and chronic treatment. The adult giant fiber preparation was used to examine the effects of phenytoin physiologically. Treated eas(2) flies showed changes in their response to normal stimulation as well as alterations in seizure threshold in response to high frequency stimulation. Gabapentin was also effective against two other bs mutants, bangsenseless(1) and slamdance(iso7.8), at strain-specific concentrations, while phenytoin also reduced bang-sensitive behaviors in bangsenseless(1) in a dose dependent manner. AEDs, therefore, can be used to dissect aspects of bs behavior and this model may be useful in understanding the underlying basis of seizure disorders. Copyright 2003 Wiley Periodicals, Inc. J Neurobiol 58: 503-513, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978727     DOI: 10.1002/neu.10297

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  26 in total

1.  Fighting anthrax with flies.

Authors:  Nikolaos Giagtzoglou; Hugo J Bellen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

2.  Metabolic disruption in Drosophila bang-sensitive seizure mutants.

Authors:  Tim Fergestad; Bret Bostwick; Barry Ganetzky
Journal:  Genetics       Date:  2006-04-28       Impact factor: 4.562

3.  Seizure suppression by gain-of-function escargot mutations.

Authors:  Daria S Hekmat-Scafe; Kim N Dang; Mark A Tanouye
Journal:  Genetics       Date:  2005-01-16       Impact factor: 4.562

Review 4.  Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

Authors:  Udai Bhan Pandey; Charles D Nichols
Journal:  Pharmacol Rev       Date:  2011-03-17       Impact factor: 25.468

5.  Structural mass spectrometry analysis of lipid changes in a Drosophila epilepsy model brain.

Authors:  Michal Kliman; Niranjana Vijayakrishnan; Lily Wang; John T Tapp; Kendal Broadie; John A McLean
Journal:  Mol Biosyst       Date:  2010-04-09

6.  Increased persistent Na+ current contributes to seizure in the slamdance bang-sensitive Drosophila mutant.

Authors:  Richard Marley; Richard A Baines
Journal:  J Neurophysiol       Date:  2011-03-30       Impact factor: 2.714

Review 7.  Seizure and epilepsy: studies of seizure disorders in Drosophila.

Authors:  Louise Parker; Iris C Howlett; Zeid M Rusan; Mark A Tanouye
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

8.  DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy.

Authors:  J Song; L Parker; L Hormozi; M A Tanouye
Journal:  Neuroscience       Date:  2008-07-23       Impact factor: 3.590

Review 9.  From bench to drug: human seizure modeling using Drosophila.

Authors:  Juan Song; Mark A Tanouye
Journal:  Prog Neurobiol       Date:  2007-10-26       Impact factor: 11.685

Review 10.  Drosophila melanogaster as a model organism of brain diseases.

Authors:  Astrid Jeibmann; Werner Paulus
Journal:  Int J Mol Sci       Date:  2009-02-02       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.